跳至主要内容
临床试验/JPRN-jRCTs051200115
JPRN-jRCTs051200115已完成未知

ovel gastrointestinal-mediated mechanism of action of metformin

Sakaguchi Kazuhiko0 个研究点目标入组 5 人开始时间: 2021年1月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
5

研究概览

简要总结

A PET/MRI imaging protocol (PET/MRE) was developed to allow quantification of radioactivity in a fixed volume of the intestinal tract. The glucose excretion into the intestinal lumen in metformin users was approximately 1.6 g/hour, comparable to the urinary glucose excretion in SGLT2 inhibitor users.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1.Patients with type 2 diabetes
  • 2.Patients taking more than 1000 mg of metformin hydrochloride per day
  • 3.Patients with no obvious lesions in the lower gastrointestinal tract
  • 4.Patients who were 20 years of age or older and Under 75 years old at the time of obtaining consent
  • 5.Patients who have given their voluntary written consent to participate in this clinical study

排除标准

  • 1.Patients with contraindications to scopolamine butylbromide
  • 2.Patients suffering from dementia or mental illness
  • 3.Patients with possible bowel perforation or obstruction
  • 4.Patients with metals in the body that are not amenable to PET/MRE testing
  • 5.Pregnant or breast feeding patients
  • 6.Other patients who are deemed inappropriate by the investigators of this clinical study

研究者

发起方
Sakaguchi Kazuhiko

相似试验